Cargando…

ELF5 modulates the estrogen receptor cistrome in breast cancer

Acquired resistance to endocrine therapy is responsible for half of the therapeutic failures in the treatment of breast cancer. Recent findings have implicated increased expression of the ETS transcription factor ELF5 as a potential modulator of estrogen action and driver of endocrine resistance, an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Piggin, Catherine L., Roden, Daniel L., Law, Andrew M. K., Molloy, Mark P., Krisp, Christoph, Swarbrick, Alexander, Naylor, Matthew J., Kalyuga, Maria, Kaplan, Warren, Oakes, Samantha R., Gallego-Ortega, David, Clark, Susan J., Carroll, Jason S., Bartonicek, Nenad, Ormandy, Christopher J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959601/ https://www.ncbi.nlm.nih.gov/pubmed/31895944 http://dx.doi.org/10.1371/journal.pgen.1008531

Ejemplares similares

ELF5 isoform expression is tissue-specific and significantly altered in cancer
por: Piggin, Catherine L., et al.
Publicado: (2016)

ELF5 Suppresses Estrogen Sensitivity and Underpins the Acquisition of Antiestrogen Resistance in Luminal Breast Cancer
por: Kalyuga, Maria, et al.
Publicado: (2012)

ELF5 Drives Lung Metastasis in Luminal Breast Cancer through Recruitment of Gr1+ CD11b+ Myeloid-Derived Suppressor Cells
por: Gallego-Ortega, David, et al.
Publicado: (2015)

Transcript Profiling of Elf5(+/−) Mammary Glands during Pregnancy Identifies Novel Targets of Elf5
por: Rogers, Renee L., et al.
Publicado: (2010)

Estrogen Receptor Beta Influences the Inflammatory p65 Cistrome in Colon Cancer Cells
por: Indukuri, Rajitha, et al.
Publicado: (2021)

The mammary cellular hierarchy and breast cancer
por: Oakes, Samantha R., et al.
Publicado: (2014)

Targeting cistrome and dysregulated transcriptome of post-MPN sAML
por: Verstovsek, Srdan, et al.
Publicado: (2017)

The PAX8 cistrome in epithelial ovarian cancer
por: Adler, Emily K., et al.
Publicado: (2017)

Cistrome: an integrative platform for transcriptional regulation studies
por: Liu, Tao, et al.
Publicado: (2011)

Proteogenomic analysis of Inhibitor of Differentiation 4 (ID4) in basal-like breast cancer
por: Baker, Laura A., et al.
Publicado: (2020)

Inhibitor of Differentiation 4 (ID4) represses mammary myoepithelial differentiation via inhibition of HEB
por: Holliday, Holly, et al.
Publicado: (2021)

ChIPing the cistrome of PXR in mouse liver
por: Cui, Julia Yue, et al.
Publicado: (2010)

To bind or not to bind: Cistromic reprogramming in prostate cancer
por: Shen, Michelle, et al.
Publicado: (2022)

The native cistrome and sequence motif families of the maize ear
por: Savadel, Savannah D., et al.
Publicado: (2021)

A mutation in the viral sensor 2’-5’-oligoadenylate synthetase 2 causes failure of lactation
por: Oakes, Samantha R., et al.
Publicado: (2017)

Non-Overlapping Progesterone Receptor Cistromes Contribute to Cell-Specific Transcriptional Outcomes
por: Clarke, Christine L., et al.
Publicado: (2012)

Single-Cell Transcriptomics in Cancer Immunobiology: The Future of Precision Oncology
por: Valdes-Mora, Fatima, et al.
Publicado: (2018)

ELF5 and DOK7 regulation in anti-estrogen treated cells and tumors
por: Fitzgerald, Lily M., et al.
Publicado: (2016)

The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis
por: Pomerantz, Mark M., et al.
Publicado: (2015)

Myeloid cell leukemia 1 (MCL-1), an unexpected modulator of protein kinase signaling during invasion
por: Young, Adelaide IJ, et al.
Publicado: (2017)

Andy’s Algorithms: new automated digital image analysis pipelines for FIJI
por: Law, Andrew M. K., et al.
Publicado: (2017)

The ELFE programme and project
por: Laget, J M
Publicado: (1997)

Response to supraphysiological testosterone is predicted by a distinct androgen receptor cistrome
por: Qiu, Xintao, et al.
Publicado: (2022)

Deciphering essential cistromes using genome-wide CRISPR screens
por: Fei, Teng, et al.
Publicado: (2019)

Sea-ATI unravels novel vocabularies of plant active cistrome
por: Wen, Chenjin, et al.
Publicado: (2023)

The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy
por: Law, Andrew M K, et al.
Publicado: (2017)

The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy
por: Law, Andrew M K, et al.
Publicado: (2017)

ELFE at CERN
por: Burkhardt, H
Publicado: (1999)

Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer
por: Baca, Sylvan C., et al.
Publicado: (2021)

ELFE: an electron laboratory for Europe
por: Laget, J M
Publicado: (1995)

Cistrome Explorer: an interactive visual analysis tool for large-scale epigenomic data
por: L’Yi, Sehi, et al.
Publicado: (2023)

DNA barcoding reveals ongoing immunoediting of clonal cancer populations during metastatic progression and immunotherapy response
por: Baldwin, Louise A., et al.
Publicado: (2022)

Factors that influence the androgen receptor cistrome in benign and malignant prostate cells
por: Copeland, Ben T., et al.
Publicado: (2019)

ELFE at CERN: Conceptual Design Report
por: Aulenbacher, K, et al.
Publicado: (1999)

ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss
por: Chen, Yu, et al.
Publicado: (2013)

The Nursery Elf (Poetry)
Publicado: (1881)

The ELFE project: an electron accelerator for Europe
por: Pirner, H J
Publicado: (1994)

Inclusive and semi-inclusive scattering at ELFE
por: Melnitchouk, W, et al.
Publicado: (1995)

Cancer cell line specific co-factors modulate the FOXM1 cistrome
por: Wang, Yue, et al.
Publicado: (2017)

Cistrome Data Browser: expanded datasets and new tools for gene regulatory analysis
por: Zheng, Rongbin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_iahm9ade8ibtnksqper8f7vb5d